Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 5056 AL 5070

Synaptic elimination by microglia and disturbed higher brain functions

Miyanishi K, Sato A, Kihara N, Utsunomiya R, Tanaka J.

Neurochem Int. 2021 Jan;142:104901. doi: 10.1016/j.neuint.2020.104901. Epub 2020 Nov 9.

Seven Solutions for Neuroprotection in Parkinson's Disease

Devos D, Hirsch E, Wyse R.

Mov Disord. 2021 Feb;36(2):306-316. doi: 10.1002/mds.28379. Epub 2020 Nov 13.

Potential anti-neuroinflammatory compounds from Australian plants - A review

Singh A, Raju R, Münch G.

Neurochem Int. 2021 Jan;142:104897. doi: 10.1016/j.neuint.2020.104897. Epub 2020 Nov 10.

Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: A mechanism review

Wang ZY, Liu J, Zhu Z, Su CF, Sreenivasmurthy SG, Iyaswamy A, Lu JH, Chen G, Song JX, Li M.

Biomed Pharmacother. 2021 Jan;133:110968. doi: 10.1016/j.biopha.2020.110968. Epub 2020 Nov 11.

[Care of patients with Parkinson's disease in Germany: status quo and perspectives as reflected in the digital transition]

Eggers C, Wellach I, Groppa S, Strothjohann M, Klucken J.

Nervenarzt. 2021 Jun;92(6):602-610. doi: 10.1007/s00115-020-01027-3. Epub 2020 Nov 16.

Tai Chi and Qi Gong therapies as a complementary treatment in Parkinson's disease - a systematic review

Kamieniarz A, Milert A, Grzybowska-Ganszczyk D, Opara J, Juras G.

Complement Ther Med. 2021 Jan;56:102589. doi: 10.1016/j.ctim.2020.102589. Epub 2020 Oct 9.

Transitional Care for Young People with Neurological Disorders: A Scoping Review with A Focus on Patients with Movement Disorders

McGovern E, Pringsheim T, Medina A, Cosentino C, Shalash A, Sardar Z, Fung VSC, Kurian MA, Roze E; MDS Task Force on Pediatrics.

Mov Disord. 2021 Jun;36(6):1316-1324. doi: 10.1002/mds.28381. Epub 2020 Nov 17.

Effectiveness of pharmacologic treatment for dysphagia in Parkinson's disease: a narrative review

Chang MC, Park JS, Lee BJ, Park D.

Neurol Sci. 2021 Feb;42(2):513-519. doi: 10.1007/s10072-020-04865-w. Epub 2020 Nov 17.

Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson's Disease

Kang J, Kim JW, Heo H, Lee J, Park KY, Yoon JH, Chang J.

Clin Transl Sci. 2021 Mar;14(2):606-616. doi: 10.1111/cts.12920. Epub 2020 Nov 22.

Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases

Wang M, Xie Y, Qin D.

Brain Res Bull. 2021 Jan;166:172-184. doi: 10.1016/j.brainresbull.2020.11.005. Epub 2020 Nov 14.

Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders

Santos MEHP, Olops L, Vendrame F, Tavares AHJ, Leonardo DP, de Azevedo PC, Piovesana LG, Costa FF, Fertrin KY.

Blood Cells Mol Dis. 2021 Mar;87:102511. doi: 10.1016/j.bcmd.2020.102511. Epub 2020 Nov 5.

Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells

Pons-Espinal M, Blasco-Agell L, Consiglio A.

Cell Mol Life Sci. 2021 Mar;78(5):2081-2094. doi: 10.1007/s00018-020-03700-x. Epub 2020 Nov 18.

Proteomic Complexity in Parkinson's Disease: A Redox Signaling Perspective of the Pathophysiology and Progression

Martinez-Banaclocha M.

Neuroscience. 2021 Jan 15;453:287-300. doi: 10.1016/j.neuroscience.2020.11.006. Epub 2020 Nov 17.

Controversy of TMEM230 Associated with Parkinson's Disease

Wang X, Whelan E, Liu Z, Liu CF, Smith WW.

Neuroscience. 2021 Jan 15;453:280-286. doi: 10.1016/j.neuroscience.2020.11.004. Epub 2020 Nov 17.

Esophageal and Gastric Motility Disorders in the Elderly

Sendzischew Shane MA, Moshiree B.

Clin Geriatr Med. 2021 Feb;37(1):1-16. doi: 10.1016/j.cger.2020.08.002. Epub 2020 Oct 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias